Objective: Preemptive analgesia is an antinociceptive treatment that prevents central sensitization. Antinociceptive effects of diclofenac are well-known. The aim of this study was to investigate preemptive analgesic effects of curcumin and diclofenac, before acute and infl ammatory induced pain in rat model. Material and methods: Fourty eight old female (n = 6 in each group) Wistar Albino rats were included in the study. Paw movements in response to paw fl inching in response to formalin injection or thermal stimulation were compared after curcumin (400 mg kg -1 , p.o.) and diclofenac (10 mg kg -1 , i.p.) administration. Saline was used as a control. The solvent ethanol was administered in another group of rats. Preemptive analgesic effect was signifi cant in both tests when curcumin and diclofenac was administrated before the pain stimuli. Results: Oral administration of curcumin and intraperitoneal injection of diclofenac increase the response time in hot plate test and decrease the number of fl inches in formalin test (p < 0.001 vs p < 0.05). Conclusion: These results suggest that curcumin had preemptive analgesic effects on acute thermal, and infl ammatory induced pain in rats as diclofenac (Fig. 2, Ref. 35 ). Text in PDF www.elis.sk.
Preemptive analgesia is a treatment that is initiated before and is operational during the surgical procedure in order to reduce the physiological consequences of nociceptive transmission provoked by the procedure. Owing to this 'protective' effect on the nociceptive pathways, preemptive analgesia has the potential to be more effective than a similar analgesic treatment initiated after surgery. Consequently, immediate postoperative pain may be reduced and the development of chronic pain may be prevented (1, 2) .
Experimental evidence proposes that to 'prevent' or 'preempt' the noxious input to the CNS, may be more effective than treatment. The idea of preemptive analgesia was fi rst introduced into clinical practice by Crile in 1913 (3) and further developed by Wall (4) and Woolf (5) . The defi nition of preemptive analgesia was formed by Kissin (6) . According to him, preemptive analgesia is "treatment that prevents establishment of central sensitization caused by incisional and infl ammatory injuries; it starts before incision and covers both the period of surgery and the initial postoperative period. Preemptive analgesia prevents pathologic pain that is different from physiologic pain", which means: prevention or reversal of central and peripheral sensitization.
Diclofenac sodium, 2-[(2,6-dichlorophenyl) amino] benzene acetic acid, is a non-steroidal anti-infl ammatory drug (NSAID) with an approximate relative COX-1 ⁄ COX-2 specifi city ratio of one (7) . NSAIDs inhibit the cyclo-oxygenase enzymes (COX) and decrease peripheral and central prostaglandin production. To reduce the infl ammation that accompanies tissue injury, decreasing prostaglandin production attenuates the response of the peripheral and central components of the nervous system to noxious stimuli and reduces the pain occurring in response to following noxious stimuli (8) . These properties would seem to make NSAIDs ideal drugs to use in preemptive approach.
Curcumin (diferuloylmethane) is a yellow-colored phenolic pigment, obtained from powdered rhizome of Curcuma longa, Linn. family -Zingiberacae. It is the major bioactive constituent of the oleoresin of turmeric.
Turmeric is extensively used as a spice, food preservative and coloring material in India, China and Southeast Asia (9) . Curcumin has demonstrated a wide spectrum of therapeutic effects such as anti-infl ammatory, antibacterial, antiviral, antifungal, antitumor, antispasmodic and hepatoprotective. Clinically, curcumin has been used to reduce postoperative infl ammation (10) . Safety evaluation studies indicate that both turmeric and curcumin are well tolerated at high dose ranges without any toxic effects. Thus, both turmeric and curcumin have wide potential in the development of modern medicine for treatment of various diseases (11) . In addition, curcumin has been reported to have antinociceptive activity when administered systemically. The analgesic effects of curcumin are thought to be exerted by suppression of nitrite, TNF-α, and capsaicininduced TRPV1 activity, and through the descending noradrenergic and serotonergic systems (12) (13) (14) . Furthermore, curcumin has been shown to exhibit anti-infl ammatory activity by means of inhibition of a number of different mediators including phospholipase, lipoxygenase, cyclooxygenase-2, leukotrienes, thromboxane, prostaglandins, and nitric oxide (15) (16) (17) .
The formalin test is a well-established and frequently used model to study mechanisms of pain. It produces a longlasting noxious input towards the spinal cord and the brain (18) . A subcutaneous (s.c.) injection of formalin into the rat hindpaw produces a biphasic excitatory-evoked behavioral response, results in persistent tissue damage, and induces a state with good approximation to some clinical conditions of chronic infl ammatory pain. Therefore it is widely used to evaluate infl ammatory processes, central sensitization, and different pain-mediating substances.
Preemptive analgesic effect of diclofenac is discussed in many studies, but the results are still controversial (19) (20) (21) . To date, preemptive analgesic properties of curcumin were not reported in a rat model of both acute and infl ammatory pain.
In the present study, the preemptive analgesic properties of systemically administered curcumin and diclofenac were investigated in a rat model of acute and infl ammatory pain.
Materials and methods

Animals and husbandry
For this study, prior permission for animal experimentation was obtained from the Necmettin Erbakan University Experimental Medicine Research and Application Center Ethics Committee (29 February 2012 , No: 2012 . Fourty eight old female (18 months) Wistar Albino rats, weighing 325-350g were used in this study. All animals were housed in a controlled environment, with free access to food and water and were maintained on a 12 h/12 h day/night cycle. Each animal was used only once. Each group consisted of 6 animals.
Formalin test
The formalin test was carried out as described by Tjolsen et al (18) . Rats were given normal saline (0.5 ml, i.p.), ethanol (5 %, p.o.), curcumin (400 mg kg -1 , p.o.), diclofenac (10 mg kg -1 , i.p.) before injecting formalin. Curcumin suspension was prepared in 5 % ethanol solution. Curcumin suspension was freshly prepared and administered orally at the dose of 400 mg kg -1 body weight 45 min before formalin injection. Diclofenac was given 15 min before formalin injection. The formalin test was performed by subcutaneously injecting 50 μL of 1% formalin solution into the plantar surface of the right hind paw using a 30 gauge needle. The formalin injection evoked a characteristic spontaneous fl inching behaviour, and thus the pain behavior was quantifi ed by periodically counting the number of fl inches of the injected paw. The number of fl inches was counted recorded in 10 min intervals for 60 min. The observed responses appeared biphasically and were divided into phase 1 (0-10 min) and phase 2 (11-60 min).
Hot plate test
The acute thermal pain was realized by using hot plate apparatus (MAY 9619, Ankara, Turkey). The method of hot plate test is an adaptation of that described by Eddy and Leimbach (22) . The hot plate test was performed at 55 ºC on the paw of each rat. Animals were placed on the heated smooth surface and the latency of licking, shaking of the limbs or jumping was measured. Rats were given normal saline (0. 
Drugs
Diclofenac sodium (Sigma Aldrich, St Louis, MO, USA), Curcumin (Sigma Chemicals, St Louis, MO, USA) were used. Diclofenac sodium was dissolved in normal saline. Curcumin suspension was prepared in 5 % ethanol solution.
Statistical analysis
Data were expressed as means±SEM. Differences among treated groups were statistically evaluated using the ANOVA followed by the Tukey's post-hoc test. Differences were considered signifi cant at p < 0.05. 
Results
Subcutaneous injection of formalin into the hind paw produced a biphasic fl inching response, with an early (phase 1) response lasting 5-10 min, and after a quiescent interval of 5-10 min, a subsequent late (phase 2) response up to 60 min. The paw responses observed at 10 minutes intervals during a period of 60 minutes were compared. Figure 1 shows the time course and dose-response data of curcumin and diclofenac administered before formalin injection, in the formalin test. Preemptive analgesic effects of curcumin and diclofenac sodium in formalin test were demonstrated by observation of fl inching of paw after formalin injection. Preemptive antinociceptive effects of curcumin and diclofenac administered groups in formalin test were signifi cantly different in both phase 1 and 2, compared with control group and ethanol administered groups (p<0.05) (Fig. 2) . The number of paw fl inches was signifi cantly decreased in curcumin administered group compared with diclofenac administered group in phase 1. In the early part of phase 2 (10-30 min), there was no signifi cant difference between the curcumin and diclofenac administered groups. But in 40 min of phase 2 diclofenac signifi cantly decreased the number of paw fl inches compared with curcumin.
Preemptive analgesic effects of curcumin and diclofenac sodium administered in hot plate test were demonstrated by increase in response time compared with control (p<0.001). Diclofenac sodium produced an increase in response time, which was significantly higher than curcumin in 30 and 60 min. However, curcumin administration showed a signifi cant increase in response time in 90 min compared with diclofenac administrated group (p<0.001).
No analgesic effect was observed in control and ethanol adminstered groups in hot plate tests.
Discussion
In the recent study, we demonstrated that curcumin and diclofenac sodium had preemptive analgesic effects in formalin test and in the hot plate test in rats. Preemptive analgesia can reduce both the acute and infl ammatory pain and in this way can reduce peripheral and central sensitization.
Preemptive analgesic effect was obvious with NSAIDs due to their mode of action, competing with arachidonic acid for binding to cyclooxygenase and decreasing the formation of prostaglandins (23) . Treatment with NSAIDs should be started as early as possible and should be initiated before the input of nociceptive stimuli. However, the clinical value of this technique remains still uncertain. Woolf et al (24) showed no difference with preoperative diclofenac from postoperative diclofenac in patients undergoing laparascopic tubal ligation. However, Buggy et al (25) and Gillberg et al (26) demonstrate that preoperative administration of ketorolac, piroxicam and diclofenac did reduce postoperative pain in patients undergoing laparoscopy. Our fi ndings support these results as well. It is expected that NSAIDs will play an increasing role in preemptive analgesia and pain relief in general.
The hot plate test evaluates supraspinal antinociceptive effects, and it refl ects activity in thermally sensitive afferent fi bers and activity of Aδ and C fi bers (27) . Responses in the formalin test are mediated by both the spinal and supraspinal sites. The phase 1 response of the formalin test is caused by the direct stimulation of nociceptors by formalin or tissue damage, and is thought to be an acute pain reaction. This refl ects activity that is prominent in Aβ, Aδ and high-threshold C nociceptor afferent fi bers. The phase 2 response is caused by infl ammation after formalin injection and central sensitization related to C activity. It refl ects activity in mechanically insensitive afferent fi bers and activity of Aδ and C fi bers (8) . Sensory fi bers respond to physical and chemical stimuli producing mediators with origin from tissue injury and infl ammation. These infl ammatory mediators activate or sensitize afferent fi bers, and the neural impulses originated from nociceptors are transmitted via peripheral nerves to the spinal cord and with cranial nerves to cranial nerve ganglia. Prostaglandins are among the most important mediators of infl ammatory pain. During infl ammation prostaglandin formation is induced by cyclooxygenase (COX) enzymes. NSAIDs block COX enzymes production and produce analgesia (28) . Studies have highlighted that NSAIDs do not increase the pain threshold in animal model such as tail-fl ick and hot plate tests, but they normalize the pain behavior, which is observed after tissue injury and infl ammation mechanism (29, 30) . Antigona et al (31) shows that i.p. administered diclofenac has preemptive and antinociceptive effects in acute thermal and infl ammatory induced pain.
In the present study, it was found that curcumin supressed infl ammatory pain more potently than diclofenac in the early phase of pain. It was reported that the early phase of formalin pain is a neurogenic pain and produced due to direct activation of C-fi ber nociceptors (18) . It was reported that anti-infl ammatory drugs did not affect the fi rst phase of formalin pain even when a very low formalin concentration was used (32) . The role of curcumin in formalin model of plantar pain has been tested in a previous study (33) in which curcumin administered orally failed to reduce the licking and biting behavior in acute phase. Although, it was reported that oral bioavailability of curcumin is very poor (34) , in this study we administered it orally as Tajik et al (33) used. These investigators also reported that the antinociceptive effect of curcumin on the infl ammatory pain may be related to its antiinfl ammatory property. It has been reported that curcumin has the ability to inhibit the activation of infl ammatory mediators, such as COX 2, lipooxygenase, inducible nitric oxide synthase and nuclear factor kappaB (35) . In this study, we observed that curcumin has spinal and supraspinal preemptive analgesic effects as diclofenac. With our data, we can not suggest which mechanisms underlie this effect of curcumin. However, no studies have compared the preemptive analgesic effects of curcumin and diclofenac before.
In conclusion, the present results suggest that in rats both curcumin and diclofenac have preemptive analgesic effects. Further studies must be performed to clarify the mechanism of curcumininduced preemptive analgesic effects.
